Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xian Teng

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 7, 2021
[The Relationship between Plasma sST2/Reg3α Levels and Acute Graft-Versus-Host Disease in Children After Allogeneic Hematopoietic Stem Cell Transplantation]Ai-Ping Zhang, Hao Xiong, Zhuo Wang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 19, 2024
lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagyZhu-Jian Deng, Hao-Tian Liu, Bao-Hong Yuan, et al.
Journal of Clinical and Translational Hepatology|March 2, 2022
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and ControversyZhu-Jian Deng, Le Li, Yu-Xian Teng, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 6, 2023
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2Hao-Tian Liu, Cheng-Piao Luo, Meng-Jie Jiang, et al.
BJS Open|February 21, 2023
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysisJia-Yong Su, Zhu-Jian Deng, Yu-Xian Teng, et al.
Alimentary Pharmacology & Therapeutics|March 13, 2023
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidatesYu-Xian Teng, Wan-Guang Zhang, Anthony Wing-Hung Chan, et al.
Frontiers in Oncology|February 7, 2022
Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCCLei Liu, Si Xie, Yu-Xian Teng, et al.
Infectious Agents and Cancer|May 1, 2024
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective studyDa-Long Yang, Shao-Ping Liu, Hong-Liang Wang, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 7, 2021
[The Relationship between Plasma sST2/Reg3α Levels and Acute Graft-Versus-Host Disease in Children After Allogeneic Hematopoietic Stem Cell Transplantation]Ai-Ping Zhang, Hao Xiong, Zhuo Wang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 19, 2024
lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagyZhu-Jian Deng, Hao-Tian Liu, Bao-Hong Yuan, et al.
Journal of Clinical and Translational Hepatology|March 2, 2022
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and ControversyZhu-Jian Deng, Le Li, Yu-Xian Teng, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 6, 2023
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2Hao-Tian Liu, Cheng-Piao Luo, Meng-Jie Jiang, et al.
BJS Open|February 21, 2023
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysisJia-Yong Su, Zhu-Jian Deng, Yu-Xian Teng, et al.
Alimentary Pharmacology & Therapeutics|March 13, 2023
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidatesYu-Xian Teng, Wan-Guang Zhang, Anthony Wing-Hung Chan, et al.
Frontiers in Oncology|February 7, 2022
Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCCLei Liu, Si Xie, Yu-Xian Teng, et al.
Infectious Agents and Cancer|May 1, 2024
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective studyDa-Long Yang, Shao-Ping Liu, Hong-Liang Wang, et al.
Pageof 3